Lemieux J, Maunsell E, Provencher L (2008) Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology 17:317–328. https://doi.org/10.1002/pon.1245

Article  PubMed  Google Scholar 

Hesketh PJ, Batchelor D, Golant M, Lyman GH, Rhodes N, Yardley D (2004) Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer 12:543–549. https://doi.org/10.1007/s00520-003-0562-5

Article  PubMed  Google Scholar 

McGarvey EL, Baum LD, Pinkerton RC, Rogers LM (2001) Psychological sequelae and alopecia among women with cancer. Cancer Pract 9:283–289. https://doi.org/10.1111/j.1523-5394.2001.96007.pp.x

Article  CAS  PubMed  Google Scholar 

Fisher B, Brown AM, Dimitrov V, Poisson R, Redmond C, Margolese RG, Bowman D, Wolmark N, Wickerham DL, Kardinal CG (1990) Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical adjuvant breast and Bowel Project B-15. J Clin Oncol 8:1483–1496. https://doi.org/10.1200/JCO.1990.8.9.1483

Article  CAS  PubMed  Google Scholar 

Martín M, Rodríguez-Lescure Á, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munárriz B, Rodríguez CA, Crespo C, de Alava E, López García-Asenjo JA, Guitán MD, Almenar S, González-Palacios JF, Vera F, Palacios J, Ramos M, Marco JMG, Lluch A, Alvarez I, Seguí MA, Mayordomo JI, Antón A, Baena JM, Plazaola A, Modolell A, Pelegrí, Mel JR, Aranda E, Adrover E, Álvarez JV, García Puche JL, Sánchez-Rovira P, Gonzalez S, López-Vega JM, On behalf of the GEICAM 9906 Study Investigators (2008) Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer. J Natl Cancer Inst 100:805–814. https://doi.org/10.1093/jnci/djn151

Article  CAS  PubMed  Google Scholar 

Watanabe T, Yagata H, Saito M, Okada H, Yajima T, Tamai N, Yoshida Y, Takayama T, Imai H, Nozawa K, Sangai T, Yoshimura A, Hasegawa Y, Yamaguchi T, Shimozuma K, Ohashi Y (2019) A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients. PLoS ONE 14:e0208118. https://doi.org/10.1371/journal.pone.0208118

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brien RO, Zelson JH, Schwartz AD, Pearson HA (1970) Scalp tourniquet to lessen alopecia after vincristine. N Engl J Med 283:1469. https://doi.org/10.1056/nejm197012242832621

Article  Google Scholar 

Nangia J, Wang T, Osborne C, Niravath P, Otte K, Papish S, Holmes F, Abraham J, Lacouture M, Courtright J, Paxman R, Rude M, Hilsenbeck S, Osborne CK, Rimawi M (2016) Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer: the SCALP randomized clinical trial. JAMA 317:596–605. https://doi.org/10.1001/jama.2016.20939

Article  Google Scholar 

FDA NEWS RELEASE (2017) FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy. https://www.fda.gov/news-events/press-announcements/fda-clears-expanded-use-cooling-cap-reduce-hair-loss-during-chemotherapy

de Barros Silva G, Ciccolini K, Donati A, van den Hurk C (2020) Scalp cooling to prevent chemotherapy-induced alopecia. Bras Dermatol 95:631–637. https://doi.org/10.1016/j.abd.2020.03.005

Article  Google Scholar 

Komen MMC, Smorenburg CH, Hurk CJG, Nortier JWR (2013) Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist 18:885–891. https://doi.org/10.1634/theoncologist.2012-0332

Article  PubMed  PubMed Central  Google Scholar 

Kanchanlata S, Mustansir B, Yasar AK, Ganapathi B, Thankamani M (2018) Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity - exploring the armoury of obscurity. Saudi Pharm J 26:177–190. https://doi.org/10.1016/j.jsps.2017.12.013

Article  Google Scholar 

Simone IICB, Simone NL, Simone V, Simone CB (2007) Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. Altern Ther Health Med 13:22–28

PubMed  Google Scholar 

Simone IICB, Simone NL, Simone V, Simone CB (2007) Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 2. Altern Ther Health Med 13:40–47

PubMed  Google Scholar 

Hendrix S, Handjiski B, Peters MJ, Paus R (2005) A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice. J Invest Dermatol 125:42–51. https://doi.org/10.1111/j.0022-202X.2005.23787.x

Article  CAS  PubMed  Google Scholar 

Yoneda K, Fujii M, Imaoka A, Kobayashi R, Hayashi R, Yoshida Y, Kohno T, Tsuji T (2021) Preventive effect of edaravone ointment on cyclophosphamide-chemotherapy induced alopecia. Support Care Cancer 29:6127–6134. https://doi.org/10.1007/s00520-021-06189-7

Article  PubMed  Google Scholar 

Onaolapo AY, Adebayo AA, Onaolapo OJ (2018) Oral phenytoin protects against experimental cyclophosphamide-chemotherapy induced hair loss. Pathophysiology 25:31–39. https://doi.org/10.1016/j.pathophys.2017.12.001

Article  CAS  PubMed  Google Scholar 

Zhao J, Li J, Li W, Li Y, Shan H, Gong Y, Yang B (2010) Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing. Br J Pharmacol 159:1584–1594. https://doi.org/10.1111/j.1476-5381.2009.00551.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Philpott MP, Sanders DA, Kealey T (1994) Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro. J Invest Dermatol 102:857–861. https://doi.org/10.1111/1523-1747.ep12382494

Article  CAS  PubMed  Google Scholar 

Soref CM, Fahl WE (2015) A new strategy to prevent chemotherapy and radiotherapy-induced alopecia using topically applied vasoconstrictor. Int J Cancer 136:195–203. https://doi.org/10.1002/ijc.28961

Article  CAS  PubMed  Google Scholar